We are live on ! Find out more
HF

HRT Financial Portfolio holdings

AUM $40.1B
1-Year Est. Return 58.22%
This Fund
S&P 500
This Quarter Est. Return
-1.14%
1 Year Est. Return
+58.22%
3 Year Est. Return
+133.11%
5 Year Est. Return
+158.39%
10 Year Est. Return
+582.81%
AUM
$10B
AUM Growth
-$659M
Cap. Flow
-$351M
Cap. Flow %
-3.5%
Top 10 Hldgs %
37.51%
Holding
3,451
New
1,054
Increased
594
Reduced
593
Closed
1,097

Top Buys

Rank Stock Value
1
TMUS icon
T-Mobile US
TMUS
+$120M
2
NEM icon
Newmont
NEM
+$98.8M
3
ATVI
Activision Blizzard
ATVI
+$96.4M
4
AVGO icon
Broadcom
AVGO
+$91.9M
5
AAPL icon
Apple
AAPL
+$84.3M

Sector Composition

Rank Sector Weight
1 Technology 11.46%
2 Financials 7.72%
3 Consumer Discretionary 7.01%
4 Industrials 5.74%
5 Energy 5.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CTSO icon
2076
Cytosorbents Corp
CTSO
$22.6M
$19K ﹤0.01%
+10,256
New +$29.4K
IBIO icon
2077
iBio
IBIO
$70M
$19K ﹤0.01%
+3,181
New +$27.5K
BRLIR
2078
DELISTED
Brilliant Acquisition Corporation Rights
BRLIR
$19K ﹤0.01%
93,957
-214
-0.2% -$40
WATT icon
2079
Energous
WATT
$102M
$18K ﹤0.01%
+392
New +$38.7K
LZM.WS icon
2080
Lifezone Metals Ltd Warrants
LZM.WS
$29.5M
$17K ﹤0.01%
+15,000
New +$13K
BHIL
2081
DELISTED
Benson Hill, Inc.
BHIL
$17K ﹤0.01%
+1,503
New +$46.7K
AMTI
2082
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
$17K ﹤0.01%
+113,307
New +$30.1K
CLEU
2083
DELISTED
China Liberal Education Holdings
CLEU
$16K ﹤0.01%
3
+2
+200% +$36.4K
VVOS icon
2084
Vivos Therapeutics
VVOS
$4.5M
$16K ﹤0.01%
+3,508
New +$26.5K
GRND.WS
2085
DELISTED
Grindr Inc. Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share
GRND.WS
$16K ﹤0.01%
21,420
+1,089
+5% +$820
BRSH
2086
DELISTED
Bruush Oral Care Inc. Common Stock
BRSH
$16K ﹤0.01%
+14,566
New +$47.1K
ASST icon
2087
Strive Inc
ASST
$1.05B
$15K ﹤0.01%
328
-97
-23% -$9.15K
BLIN icon
2088
Bridgeline Digital
BLIN
$14.4M
$15K ﹤0.01%
+18,899
New +$19.4K
CLNN icon
2089
Clene
CLNN
$67.5M
$15K ﹤0.01%
+1,589
New +$22K
GRFX
2090
DELISTED
Graphex Group
GRFX
$15K ﹤0.01%
+2,659
New +$16.3K
IVP
2091
DELISTED
Inspire Veterinary Partners
IVP
$15K ﹤0.01%
+5
New +$23.9K
NUVB icon
2092
Nuvation Bio
NUVB
$2.32B
$15K ﹤0.01%
+11,819
New +$19.7K
CNSY
2093
Cerenome, Inc. Common Stock
CNSY
$26.4M
$15K ﹤0.01%
+449
New +$24.1K
VBIV
2094
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$15K ﹤0.01%
+23,811
New +$29.2K
LIAN
2095
DELISTED
LianBio American Depositary Shares
LIAN
$15K ﹤0.01%
+10,563
New +$20.1K
BAERW icon
2096
Bridger Aerospace Warrant
BAERW
$8.48M
$14K ﹤0.01%
49,968
GAN
2097
DELISTED
GAN Ltd
GAN
$14K ﹤0.01%
+12,560
New +$19.7K
HYFM icon
2098
Hydrofarm Holdings
HYFM
$7.62M
$14K ﹤0.01%
1,213
-2,626
-68% -$29.3K
NIOBW
2099
NioCorp Developments Ltd Warrant
NIOBW
$79.3M
$14K ﹤0.01%
24,975
YHC
2100
LQR House Inc
YHC
$2.33M
0

Similar funds

HRT Financial's Q3 2023 Portfolio in Review

As of Q3 2023, HRT Financial held 3,451 positions worth $10B, down 6.2% from $10.7B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

HRT Financial withdrew a net $351M in Q3 2023, closing 1,097 positions and reducing 593 holdings. Its most notable exit was Blackstone, an estimated $146M position sold in full.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 8.5% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, HRT Financial opened a new position in Broadcom worth $88.1M.

  • HRT Financial's largest Q3 2023 buy was Broadcom: 1,060,690 shares worth $88.1M.
  • HRT Financial added most to T-Mobile US in Q3 2023, an estimated $120M increase.
  • HRT Financial's biggest Q3 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $773M.
  • HRT Financial fully exited Blackstone in Q3 2023, selling an estimated $146M.
  • HRT Financial's ten largest holdings make up 38% of its $10B portfolio in Q3 2023.
  • HRT Financial opened 1,054 new positions and closed 1,097 in Q3 2023.
  • HRT Financial's portfolio value fell 6.2% quarter-over-quarter to $10B.

Based on HRT Financial's 13F filing for Q3 2023, filed 13 Nov 2023.